How a Top 30 Pharma Company Leverages Medrio

A top 30 pharma company wanted full control over its global phase IV trials. But with five different CROs across Europe and Asia using different technologies, bringing that work in-house was a major challenge.

Medrio was chosen for its enterprise-grade security, validation, and compliance, without the cost and complexity of legacy systems.

In this case study, see how this top pharma utilized Medrio EDC and ePRO to:

Standardize global data capture across all Phase IV studies
Enable internal study management with minimal support
Integrate EDC and ePRO for improved data visibility and analysis

Complete this form to download this Case Study.

"*" indicates required fields

Instagram

This field is for validation purposes and should be left unchanged.

First Name*

Last Name*

Email Address*

Company Name*

Marketing Email Subscription Preferences

I authorize Medrio to contact me with relevant content, products, and services. You may unsubscribe at any time.

Legal basis for processing contact's data*

I have read Medrio's privacy policy, and consent to my data being stored and processed. *